<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02310672</url>
  </required_header>
  <id_info>
    <org_study_id>AC-055-403</org_study_id>
    <nct_id>NCT02310672</nct_id>
  </id_info>
  <brief_title>REPAIR: Right vEntricular Remodeling in Pulmonary ArterIal hypeRtension</brief_title>
  <acronym>REPAIR</acronym>
  <official_title>A Prospective, Multicenter, Single-arm, Open-label, Phase 4 Study to Evaluate the Effects of Macitentan on Right vEntricular Remodeling in Pulmonary ArterIal hypeRtension Assessed by Cardiac Magnetic Resonance Imaging</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Actelion</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Actelion</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study evaluates the effect of macitentan on right ventricular and hemodynamic properties
      in patients with symptomatic pulmonary arterial hypertension. Patients are treated with
      macitentan for 1 year. Patients undergo right heart catheterization (RHC) at baseline and
      Week 26. They also undergo cardiac magnetic resonance imaging (MRI) at baseline, Week 26 and
      Week 52. Safety is monitored throughout the study. The study has three stub-studies. Each
      patient can participate in no sub-study or in one sub-study. The sub-studies are: (1)
      metabolism sub-study (with PET-MR scans); (2) biopsy sub-study (biopsies taken during the
      RHC); (3) Echo sub-study.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 1, 2015</start_date>
  <completion_date type="Anticipated">May 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To evaluate the effect of macitentan on right ventricular and hemodynamic properties in patients with symptomatic pulmonary arterial hypertension (PAH).</measure>
    <time_frame>Baseline to Week 26</time_frame>
    <description>Change in Right Ventricular Stroke Volume and ratio of Week 26 to baseline PVR</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>To investigate the effect of macitentan on ventriculo-arterial coupling in patients with symptomatic PAH.</measure>
    <time_frame>baseline to Week 26</time_frame>
    <description>Change in arterial elastance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To evaluate the safety and tolerability of macitentan in patients with symptomatic PAH.</measure>
    <time_frame>Base line to 30 days after End of Treatment (Week 52)</time_frame>
    <description>Treatment-emergent adverse events (AEs) up to 30 days after EOT.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Pulmonary Arterial Hypertension</condition>
  <arm_group>
    <arm_group_label>Macitentan</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All patients take open-label macitentan 10mg o.d.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Macitentan</intervention_name>
    <description>All patients take open-label macitentan 10mg o.d.</description>
    <arm_group_label>Macitentan</arm_group_label>
    <other_name>ACT-064992</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Signed informed consent prior to any study-mandated procedure

          2. Symptomatic pulmonary arterial hypertension (PAH)

          3. World Health Organization (WHO) Functional Class (FC) I to III

          4. PAH etiology belonging to one of the following groups according to Nice
             classification:

               -  Idiopathic PAH

               -  Heritable PAH

               -  Drug- and toxin-induced PAH

               -  PAH associated with congenital heart diseases: only simple (atrial septal defect,
                  ventricular septal defect, patent ductus arteriosus) congenital systemic to
                  pulmonary shunts at least 2 year post surgical repair

          5. Hemodynamic diagnosis of PAH confirmed by right heart catheterization (RHC) during
             screening showing:

             • mean pulmonary arterial pressure (mPAP) ≥ 25 mmHg and

               -  PCWP (pulmonary capillary wedge pressure) or left ventricular end diastolic
                  pressure (LVEDP) ≤ 12 mmHg and pulmonary vascular resistance (PVR) ≥ 4 Wood Units
                  (WU) (320 dyn.sec.cm-5) or

               -  12 mmHg ≤ PCWP or LVEDP ≤ 15 mmHg and PVR ≥ 6WU (480 dyn.sec.cm-5)

          6. 6-minute walk distance (6MWD) ≥ 150 m during screening

          7. For patients treated with oral diuretics, treatment dose must have been stable at
             least 1 month prior to RHC during the screening period

          8. For patients treated with phosphodiesterase type-5 (PDE-5) inhibitors, treatment dose
             must have been stable at least 3 months prior to RHC during the screening period

          9. For patients treated with beta blockers, treatment dose must have been stable at least
             1 month prior to the RHC during the screening period

         10. Men or women ≥18 and &lt; 65 years

         11. Women of childbearing potential (defined in protocol) must:

               -  Have a negative serum pregnancy test during screening and a negative urine
                  pregnancy test on Day 1, and

               -  Agree to use reliable methods of contraception (defined in protocol) from
                  screening up to 30 days after study treatment discontinuation, and

               -  Agree to perform monthly pregnancy tests up to 30 days after study treatment
                  discontinuation

        Exclusion Criteria:

          1. Body weight &lt; 40 kg

          2. Body mass index (BMI) &gt; 35kg/m2. For patients with 30kg/m2 &lt; BMI &lt; 35kg/m2, an
             eligibility form will be submitted to a Steering Committee member who will reserve the
             right to exclude the patient.

          3. Pregnancy, breastfeeding or intention to become pregnant during the study

          4. Recently started (&lt; 8 weeks prior to informed consent signature) or planned
             cardio-pulmonary rehabilitation program

          5. Known concomitant life-threatening disease with a life expectancy &lt; 12 months

          6. Any condition likely to affect protocol or treatment compliance

          7. Hospitalization for PAH within 3 months prior to informed consent signature

          8. Left atrial volume indexed for body surface area ≥ 43mL/m2 by echocardiography or
             cardiac MRI

          9. Valvular disease grade 2 or higher

         10. History of pulmonary embolism or deep vein thrombosis

         11. Documented moderate to severe chronic obstructive pulmonary disease

         12. Documented moderate to severe restrictive lung disease

         13. Historical evidence of significant coronary artery disease established by:

               -  History of myocardial infarction or

               -  More than 50% stenosis in a coronary artery (by percutaneous coronary
                  intervention or angiography) or

               -  Elevation of the ST segment on electrocardiogram or

               -  History of coronary artery bypass grafting or

               -  Stable angina

         14. Diabetes mellitus

         15. Moderate to severe renal insufficiency (calculated creatinine clearance &lt; 60
             mL/min/1.73 m2)

         16. Cancer

         17. Systolic blood pressure &lt; 90 mmHg

         18. Severe hepatic impairment (with or without cirrhosis) according to National Cancer
             Institute organ dysfunction working group criteria, defined as total bilirubin &gt; 3 ×
             upper limit of the normal range (ULN) accompanied by an aspartate aminotransferase
             (AST) elevation &gt; ULN at Screening.

         19. Hemoglobin &lt; 100g/L

         20. AST and/or alanine aminotransferase (ALT) &gt; 3× ULN

         21. Need for dialysis

         22. Responders to acute vasoreactivity test based on medical history

         23. Prior use of endothelin receptor antagonists (ERAs), stimulators of soluble guanylate
             cyclase or prostacyclin or prostacyclin analogues

         24. Treatment with strong inducers of cytochrome P450 isozyme 3A4 (CYP3A4) within 4 weeks
             prior to study treatment initiation (e.g., carbamazepine, rifampicin, rifabutin,
             phenytoin and St. John's Wort)

         25. Treatment with strong inhibitors of CYP3A4 within 4 weeks prior to study treatment
             initiation (e.g., ketoconazole, itraconazole, voriconazole, clarithromycin,
             telithromycin, nefazodone, ritonavir, and saquinavir)

         26. Treatment with another investigational drug (planned, or taken within the 3 months
             prior to study treatment initiation).

         27. Hypersensitivity to any ERA or any excipients of the formulation of macitentan
             (lactose, magnesium stearate, microcrystalline cellulose, povidone, sodium starch
             glycolate, polyvinyl alcohol, polysorbate, titanium dioxide, talc, xanthan gum, and
             lecithin soya)

         28. Claustrophobia

         29. Permanent cardiac pacemaker, automatic internal cardioverter

         30. Metallic implant (e.g., defibrillator, neurostimulator, hearing aid, permanent use of
             infusion device)

         31. Atrial fibrillation, multiple premature ventricular or atrial contractions, or any
             other condition that would interfere with proper cardiac gating during MRI.

         32. For patients enrolling in the metabolism sub-study only: glucose intolerance

         33. For patients enrolling in the biopsy sub-study only: PAH etiology belonging to Nice
             classification 1.4.4: PAH associated with congenital heart diseases
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Loïc Perchenet</last_name>
    <role>Study Director</role>
    <affiliation>Actelion</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lo&amp;amp;amp;amp;amp;#239;c Perchenet</last_name>
    <email>loic.perchenet@actelion.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Massachussetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Loic Perchenet</last_name>
      <email>loic.perchenet@actelion.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Boston University</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02118</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>University of Minnesota</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Loic Perchenet</last_name>
      <email>loic.perchenet@actelion.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Washington University School of Medicine</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Loic Perchenet</last_name>
      <email>loic.perchenet@actelion.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Atlantic Center for Research / Atlantic Health System</name>
      <address>
        <city>Morristown</city>
        <state>New Jersey</state>
        <zip>O7960</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Rudgers New Jersey Medical School</name>
      <address>
        <city>New Brunswick</city>
        <state>New Jersey</state>
        <zip>08901</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Loic Perchenet</last_name>
      <email>loic.perchenet@actelion.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cornell University</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Loic Perchenet</last_name>
      <email>loic.perchenet@actelion.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Loic Perchenet</last_name>
      <email>loic.perchenet@actelion.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Texas Southwestern Medical</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Loic Perchenet</last_name>
      <email>loic.perchenet@actelion.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Luke's Medical Center</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Loic Perchenet</last_name>
      <email>loic.perchenet@actelion.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Prince Charles Hospital</name>
      <address>
        <city>Chermside</city>
        <state>Queensland</state>
        <zip>4032</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Loic Perchenet</last_name>
      <email>loic.perchenet@actelion.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital Gabriel Montpied</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63003</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Loic Perchenet</last_name>
      <email>loic.perchenet@actelion.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Michallon</name>
      <address>
        <city>La Tronche</city>
        <zip>38700</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Loic Perchenet</last_name>
      <email>loic.perchenet@actelion.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>&quot;CHRU de Lille - Hôpital Albert Calmette &quot;</name>
      <address>
        <city>Lille Cedex</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Loic Perchenet</last_name>
      <email>loic.perchenet@actelion.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital de Brabois</name>
      <address>
        <city>Nancy</city>
        <zip>54511</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Loic Perchenet</last_name>
      <email>loic.perchenet@actelion.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Laennec</name>
      <address>
        <city>Nantes Cedex 01</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Loic Perchenet</last_name>
      <email>loic.perchenet@actelion.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Pasteur</name>
      <address>
        <city>Nice</city>
        <zip>06002</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Loic Perchenet</last_name>
      <email>loic.perchenet@actelion.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Européen Georges-Pompidou</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Loic Perchenet</last_name>
      <email>loic.perchenet@actelion.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>DRK Kliniken Berlin Köpenick</name>
      <address>
        <city>Berlin</city>
        <zip>12559</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Medizinische Klinik und Poliklinik II Universitätsklinik Bonn</name>
      <address>
        <city>Bonn</city>
        <zip>53105</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Loic Perchenet</last_name>
      <email>loic.perchenet@actelion.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Giessen und Marburg</name>
      <address>
        <city>Giessen</city>
        <zip>35392</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Medizinische Hochschule Hannover</name>
      <address>
        <city>Hannover</city>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Thoraxklinik am Universitätsklinikum Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <zip>69126</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Loic Perchenet</last_name>
      <email>loic.perchenet@actelion.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Köln Herzzentrum / Klinik III für Innere Medizin</name>
      <address>
        <city>Köln</city>
        <zip>50924</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Loic Perchenet</last_name>
      <email>loic.perchenet@actelion.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsmedizin der Johannes Gutenberg-Universität Mainz Centrum für Thrombose und Hämostase</name>
      <address>
        <city>Mainz</city>
        <zip>55131</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Loic Perchenet</last_name>
      <email>loic.perchenet@actelion.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum der Universität München</name>
      <address>
        <city>München</city>
        <zip>81377</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Grantham Hospital, Cardiac Medical Unit</name>
      <address>
        <city>Hong Kong</city>
        <zip>999077</zip>
        <country>Hong Kong</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Loic Perchenet</last_name>
      <email>loic.perchenet@actelion.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Queen Mary Hospital</name>
      <address>
        <city>Hong Kong</city>
        <zip>999077</zip>
        <country>Hong Kong</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Loic Perchenet</last_name>
      <email>loic.perchenet@actelion.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>United Christian Hospital</name>
      <address>
        <city>Hong Kong</city>
        <zip>999077</zip>
        <country>Hong Kong</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Loic Perchenet</last_name>
      <email>loic.perchenet@actelion.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pulmonology institute, Soroka Medical Center</name>
      <address>
        <city>Beer-Sheva</city>
        <zip>84101</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Loic Perchenet</last_name>
      <email>loic.perchenet@actelion.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shaare Zedek Medical Center</name>
      <address>
        <city>Jerusalem</city>
        <zip>9103102</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Loic Perchenet</last_name>
      <email>loic.perchenet@actelion.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Policlinico Sant'Orsola-Malpighi</name>
      <address>
        <city>Bologna</city>
        <zip>40138</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Loic Perchenet</last_name>
      <email>loic.perchenet@actelion.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fondazione IRCCS Policlinico San Matteo Ambulatorio Scompenso Cardiaco e Trapianti</name>
      <address>
        <city>Pavia</city>
        <zip>27100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Loic Perchenet</last_name>
      <email>loic.perchenet@actelion.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Pulau Pinang</name>
      <address>
        <city>George Town</city>
        <zip>10990</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Loic Perchenet</last_name>
      <email>loic.perchenet@actelion.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institut Jantung Negara (National Heart Institute)</name>
      <address>
        <city>Kuala Lumpur</city>
        <zip>50400</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Loic Perchenet</last_name>
      <email>loic.perchenet@actelion.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>VU University Medical Center (VUMC)</name>
      <address>
        <city>Amsterdam</city>
        <zip>1081 HV</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Loic Perchenet</last_name>
      <email>loic.perchenet@actelion.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Maastricht UMC+</name>
      <address>
        <city>HX Maastricht</city>
        <zip>6229</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>St. Antonius Ziekenhuis</name>
      <address>
        <city>Nieuwegein</city>
        <zip>3435 CM</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Loic Perchenet</last_name>
      <email>loic.perchenet@actelion.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Radboud UMC</name>
      <address>
        <city>Nijmegen</city>
        <zip>6525 GA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Loic Perchenet</last_name>
      <email>loic.perchenet@actelion.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Erasmus University medical Center</name>
      <address>
        <city>Rotterdam</city>
        <zip>3000 CA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Loic Perchenet</last_name>
      <email>loic.perchenet@actelion.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Russian Cardiology Scientific and Production Complex</name>
      <address>
        <city>Moscow</city>
        <zip>121552</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Loic Perchenet</last_name>
      <email>loic.perchenet@actelion.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Almazov Federal North-West Medical Research Centre of Department of Health</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>197341</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Loic Perchenet</last_name>
      <email>loic.perchenet@actelion.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>National University Hospital - The Heart Institute - Cardiac Department</name>
      <address>
        <city>Singapore</city>
        <zip>119228</zip>
        <country>Singapore</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Loic Perchenet</last_name>
      <email>loic.perchenet@actelion.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>National Heart Centre (NHC) Singapore</name>
      <address>
        <city>Singapore</city>
        <zip>169609</zip>
        <country>Singapore</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Loic Perchenet</last_name>
      <email>loic.perchenet@actelion.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Papworth Hospital NHS Trust</name>
      <address>
        <city>Cambridge</city>
        <zip>CB23 3RE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Golden Jubilee National Hospital</name>
      <address>
        <city>Glasgow</city>
        <zip>G81 4DY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Loic Perchenet</last_name>
      <email>loic.perchenet@actelion.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Royal Free Hospital</name>
      <address>
        <city>London</city>
        <zip>NW3 2QG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Loic Perchenet</last_name>
      <email>loic.perchenet@actelion.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Brompton Hospital</name>
      <address>
        <city>London</city>
        <zip>SW3 6NP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Loic Perchenet</last_name>
      <email>loic.perchenet@actelion.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hammersmith Hospital Imperial College Healthcare NHS Trust</name>
      <address>
        <city>London</city>
        <zip>W12 0HS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Loic Perchenet</last_name>
      <email>loic.perchenet@actelion.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>&quot;Sheffield Teaching Hospitals NHS Foundation Trust Royal Hallamshire Hospital&quot;</name>
      <address>
        <city>Sheffield</city>
        <zip>S10 2JF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Loic Perchenet</last_name>
      <email>loic.perchenet@actelion.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>France</country>
    <country>Germany</country>
    <country>Hong Kong</country>
    <country>Israel</country>
    <country>Italy</country>
    <country>Malaysia</country>
    <country>Netherlands</country>
    <country>Russian Federation</country>
    <country>Singapore</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 4, 2014</study_first_submitted>
  <study_first_submitted_qc>December 5, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 8, 2014</study_first_posted>
  <last_update_submitted>May 19, 2017</last_update_submitted>
  <last_update_submitted_qc>May 19, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pulmonary Arterial Hypertension</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
    <mesh_term>Ventricular Remodeling</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Macitentan</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

